|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 487/04 | |
| A61K 31/4184 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2217603 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08837011.9 |
| Europos patento paraiškos padavimo data | 2008-10-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-08-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-11-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/079439 |
| Data | 2008-10-10 |
| (87) | Numeris | WO 2009/049109 |
| Data | 2009-04-16 |
| (30) | Numeris | Data | Šalis |
| 979654 P | 2007-10-12 | US |
| (72) |
ZHU, Guidong, US
|
| (73) |
AbbVie Bahamas Ltd.,
Sassoon House Shirley Street & Victoria Avenue, New Providence, Nassau,
BS
|
| (54) | 2-((R)-2-METHYLPYRROLIDIN-2-YL)-1H-BENZIMIDAZOLE-4-CARBOXAMIDE CRYSTALLINE FORM 2 |
| 2-((R)-2-METHYLPYRROLIDIN-2-YL)-1H-BENZIMIDAZOLE-4-CARBOXAMIDE CRYSTALLINE FORM 2 |